Healthcare - Biotechnology - NASDAQ - CH
$ 48.83
-6.99 %
$ 3.08 B
Market Cap
-38.45
P/E
INCOME STATEMENT
0
REVENUE
-54.1 M
OPERATING INCOME
-44.1 M
NET INCOME
EFFICIENCY
Earnings Waterfall
MoonLake Immunotherapeutics
| Revenue | 0 |
| Cost Of Revenue | 13.2 K |
| Gross Profit | -13.2 K |
| Operating Expenses | 54.1 M |
| Operating Income | -54.1 M |
| Other Expenses | -10 M |
| Net Income | -44.1 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|
| REVENUE | ||||
| Revenue | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||
| Cost Of Revenue | 13.2 K | 12.4 K | 4.97 K | 0 |
| Gross Profit | 13.2 K | 12.4 K | 4.97 K | 0 |
| OPERATING INCOME | ||||
| Operating Expenses | 54.1 | 65.1 | 53.6 | 0.1 |
| Selling, General and Administrative Expenses | 22.3 | 23.0 | 18.0 | 0.1 |
| Research and Development Expenses | 31.8 | 42.0 | 35.5 | 0 |
| Operating Income | (54.1) | (65.1) | (53.6) | (0.1) |
| PRE-TAX INCOME | ||||
| Interest Income Expense | 0 | (0.6) | 0 | 0 |
| Total Other Income | 10.1 | 0.6 | 10.7 | 14.9 K |
| Pre-Tax Income | (44.0) | (64.5) | (53.6) | 90.8 K |
| NET INCOME | ||||
| Tax Provision | 94.4 K | 36.4 K | 4.76 K | (0.2) |
| Net Income | (36.0) | (64.5) | (53.6) | 90.8 K |
| EPS | 0.73 | 2.2 | 6.84 | 0.0061 |